Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeanette Harris

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
AORN Journal|May 1, 2018
Success of a Colorectal Surgical Site Infection Prevention Bundle in a Multihospital SystemJeanette Harris
Women'S Health Reports (New Rochelle, N.Y.)|October 11, 2024
A Collaborative Quality Improvement Project to Reduce Surgical Site Infection in Cesarean DeliveryJeanette Harris, Mandy Spitzer
Surgical Infections|April 1, 2015
A journey to zero: reduction of post-operative cesarean surgical site infections over a five-year periodEvelyn Hickson, Jeanette Harris, David Brett
Women & Health|December 19, 2002
Environmental, policy, and cultural factors related to physical activity in well-educated urban African American womenDeborah Rohm Young, Xiaoxing He, Jeanette Harris, et al.
HIV Clinical Trials|April 19, 2011
Reduced emergence of the M184V/I resistance mutation when antiretroviral-naïve subjects use emtricitabine versus lamivudine in regimens composed of two NRTIs plus the NNRTI efavirenzDamian J McColl, Nicolas Margot, Shan-Shan Chen, et al.
AIDS Research and Human Retroviruses|December 14, 2004
Pharmacokinetic and pharmacodynamic characteristics of emtricitabine support its once daily dosing for the treatment of HIV infectionLaurene H Wang, John Begley, Robert L St Claire, et al.
Journal of Community Genetics|June 7, 2026
"I felt like a lone ranger": experiences of Australian families living with KIF1A-Associated Neurological DisorderKara Miwa-Dale, Kimberley Norman, Belinda Dawson-McClaren, et al.
Antiviral Research|December 10, 2008
Development of a replicon-based phenotypic assay for assessing the drug susceptibilities of HCV NS3 protease genes from clinical isolatesXiaoping Qi, Andrew Bae, Shan Liu, et al.
Antimicrobial Agents and Chemotherapy|September 22, 2010
Susceptibility of treatment-naive hepatitis C virus (HCV) clinical isolates to HCV protease inhibitorsAndrew Bae, Siu-Chi Sun, Xiaoping Qi, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2012
Characterization of resistance to the protease inhibitor GS-9451 in hepatitis C virus-infected patientsHadas Dvory-Sobol, Kelly A Wong, Karin S Ku, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
AORN Journal|May 1, 2018
Success of a Colorectal Surgical Site Infection Prevention Bundle in a Multihospital SystemJeanette Harris
Women'S Health Reports (New Rochelle, N.Y.)|October 11, 2024
A Collaborative Quality Improvement Project to Reduce Surgical Site Infection in Cesarean DeliveryJeanette Harris, Mandy Spitzer
Surgical Infections|April 1, 2015
A journey to zero: reduction of post-operative cesarean surgical site infections over a five-year periodEvelyn Hickson, Jeanette Harris, David Brett
Women & Health|December 19, 2002
Environmental, policy, and cultural factors related to physical activity in well-educated urban African American womenDeborah Rohm Young, Xiaoxing He, Jeanette Harris, et al.
HIV Clinical Trials|April 19, 2011
Reduced emergence of the M184V/I resistance mutation when antiretroviral-naïve subjects use emtricitabine versus lamivudine in regimens composed of two NRTIs plus the NNRTI efavirenzDamian J McColl, Nicolas Margot, Shan-Shan Chen, et al.
AIDS Research and Human Retroviruses|December 14, 2004
Pharmacokinetic and pharmacodynamic characteristics of emtricitabine support its once daily dosing for the treatment of HIV infectionLaurene H Wang, John Begley, Robert L St Claire, et al.
Journal of Community Genetics|June 7, 2026
"I felt like a lone ranger": experiences of Australian families living with KIF1A-Associated Neurological DisorderKara Miwa-Dale, Kimberley Norman, Belinda Dawson-McClaren, et al.
Antiviral Research|December 10, 2008
Development of a replicon-based phenotypic assay for assessing the drug susceptibilities of HCV NS3 protease genes from clinical isolatesXiaoping Qi, Andrew Bae, Shan Liu, et al.
Antimicrobial Agents and Chemotherapy|September 22, 2010
Susceptibility of treatment-naive hepatitis C virus (HCV) clinical isolates to HCV protease inhibitorsAndrew Bae, Siu-Chi Sun, Xiaoping Qi, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2012
Characterization of resistance to the protease inhibitor GS-9451 in hepatitis C virus-infected patientsHadas Dvory-Sobol, Kelly A Wong, Karin S Ku, et al.
Pageof 2